期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
Effects of different doses in continuous veno-venous hemofiltration on plasma lactate in critically ill patients 被引量:5
1
作者 Liu Yongjun Ouyang Bin Chen Juan Chen Minying Ma Jie Wu Jianfeng Huang Shunwei Li Lifen Liu Zimeng Guan Xiangdong 《Chinese Medical Journal》 SCIE CAS CSCD 2014年第10期1827-1832,共6页
Background Many studies have shown that continuous renal replacement therapy (CRRT) could clean lactate and treat the hyper-lactatemia.On the contrary,some other studies found that filter lactate clearance only acco... Background Many studies have shown that continuous renal replacement therapy (CRRT) could clean lactate and treat the hyper-lactatemia.On the contrary,some other studies found that filter lactate clearance only accounted for a very small part of total lactate clearance and the hemofilter's contribution to the overall lactate clearance was negligible.The objective of this study was to evaluate the effects of various doses of continuous veno-venous hemofiltration (CWH) on plasma lactate elimination in critically ill patients.Methods Patients were divided into three groups according to their incipient plasma lactate concentration.Group A:lactate≤2 mmol/L,group B:lactate 2-5 mmol/L,group C:lactate ≥5 mmol/L.Three different doses (20 ml.kg-1.h-1,35ml·kg-1·h-1 and 45 ml.kg1.h-1) of CWH were applied to critically ill patients who experiencing CWH.The concentrations of plasma lactate in pre-(A),post-dialyzer (V) sites and ultrafiltrate were measured after each dosage of CWH was carried out for 30 minutes.Rate of lactate clearance by the filter (RLC) and filter lactate clearance (FLC) and Lactate-Sieving Coefficient (LSC) were calculated under different circumstances,including different doses of CWH and different incipient lactate levels.Results Fifteen patients were enrolled and 104 blood samples were drawn and lactate concentrations were measured in this study.RLC was found increased ((9.36±9.73) mmol/h,(13.92±12.56) mmol/h and (16.52±12.71) mmol/h,P <0.05respectively) with the dose of CWH increased.RLC was also increased ((3.46±1.46),(10.38±5.50) and (24.53±14.69) mmol/h,P <0.05 respectively) with the incipient lactate increased.FLC was increased ((1.95±0.63),(2.95±0.74) and (3.45±0.54) L/h,P <0.05 respectively) with the dose of CVVH increased.There was no significant difference of LSC in different doses of CWH and different incipient lactate levels.Conclusions Plasma lactate can be eliminated by CWH and different doses of CWH affect the rate of lactate clearance in critically ill patients. 展开更多
关键词 continuous veno-venoous hemofiltration LACTATE critical illness
原文传递
无主机床边连续静静脉血液透析滤过在肾衰竭中的应用 被引量:1
2
作者 张维真 陈亨健 +2 位作者 吴红梅 鲍华英 武新生 《实用儿科临床杂志》 CAS CSCD 北大核心 2003年第12期960-962,共3页
目的 探讨无主机床边连续静静脉血液透析滤过 (CVVHDF)在肾衰竭中的应用。方法 采用无主机床边CVVHDF治疗 6例肾衰竭并其他脏器损伤危重患儿。结果 CVVHDF治疗后全身水肿、肺水肿消失 ,重症高血压得以纠正。与治疗前比较血BUN、Cr显... 目的 探讨无主机床边连续静静脉血液透析滤过 (CVVHDF)在肾衰竭中的应用。方法 采用无主机床边CVVHDF治疗 6例肾衰竭并其他脏器损伤危重患儿。结果 CVVHDF治疗后全身水肿、肺水肿消失 ,重症高血压得以纠正。与治疗前比较血BUN、Cr显著降低 ,高血钾、低钠、低氯纠正 (P <0 .0 1)。高AG(阴离子间隙 )代谢性酸中毒纠正 ;血 pH显著升高 (P <0 .0 5 ) ;HCO-3 、BE显著升高、AG显著降低 (P均 <0 .0 1)。结论 CVVHDF在并肾衰竭不宜搬动危重儿是行之有效的治疗方法之一。其血管通路建立可采用单针双腔中心静脉插管留置术 。 展开更多
关键词 连续静静脉血液透析滤过 肾衰竭 抢救
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部